Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
September 30, 2026 292.74M
June 30, 2026 257.03M
March 31, 2026 276.30M
December 31, 2025 336.08M
September 30, 2025 375.80M
June 30, 2025 292.93M
March 31, 2025 320.32M
December 31, 2024 258.11M
September 30, 2024 213.07M
June 30, 2024 311.71M
March 31, 2024 305.70M
December 31, 2023 424.15M
September 30, 2023 467.80M
June 30, 2023 458.43M
March 31, 2023 504.48M
December 31, 2022 526.24M
September 30, 2022 571.06M
June 30, 2022 515.40M
March 31, 2022 585.11M
December 31, 2021 450.50M
September 30, 2021 469.98M
June 30, 2021 383.79M
Date Value
March 31, 2021 409.78M
December 31, 2020 299.37M
September 30, 2020 74.94M
June 30, 2020 20.96M
March 31, 2020 27.33M
December 31, 2019 28.27M
September 30, 2019 32.12M
June 30, 2019 26.98M
March 31, 2019 29.43M
December 31, 2018 31.03M
September 30, 2018 32.60M
June 30, 2018 30.60M
March 31, 2018 28.48M
December 31, 2017 26.48M
September 30, 2017 26.05M
June 30, 2017 28.87M
March 31, 2017 27.37M
December 31, 2016 20.87M
September 30, 2016 8.205M
June 30, 2016 16.06M
March 31, 2016
December 31, 2015 0.489M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Quest Diagnostics, Inc. 797.00M
Labcorp Holdings, Inc. 261.80M
OPKO Health, Inc. 390.22M
Psychemedics Corp. --
NeoGenomics, Inc. 139.28M